Literature DB >> 18458961

[Aims of the guidelines for diagnostic and treatment of fibromyalgia syndrome].

M Schiltenwolf1, W Eich, R Schmale-Grete, W Häuser.   

Abstract

The guidelines aim to provide all professions involved in the treatment of fibromyalgia syndrome (FMS) a systematically developed basis for the diagnosis and therapy of FMS. Diagnostic criteria and empirically founded therapies are presented to reduce the currently insufficient medical care for FMS patients. Recommendations for a stepwise therapeutic approach are designed to improve the quality of medical care, the implementation of effective treatment options as well as reduction of the utilization of non-effective therapies and improvement of the patient-physician relationship. Recommendations on the coordination of medical care (inpatient and outpatient treatment by family physicians, medical specialists and other medical professions, care in emergency and rehabilitation hospitals) aim to reduce rivalry between medical societies and to promote an optimal use of resources. A patient version of the guidelines is aimed at improving patients' knowledge on the etiology and effective treatment options available thus promoting an effective self-management of patients.

Entities:  

Mesh:

Year:  2008        PMID: 18458961     DOI: 10.1007/s00482-008-0669-1

Source DB:  PubMed          Journal:  Schmerz        ISSN: 0932-433X            Impact factor:   1.107


  7 in total

1.  [The German program for disease management guidelines. Background, methods, and development process].

Authors:  Günter Ollenschläger; Ina Kopp; Monika Lelgemann; Sylvia Sänger; Lothar Heymans; Henning Thole; Henrike Trapp; Wilfried Lorenz; Hans-Konrad Selbmann; Albrecht Encke
Journal:  Med Klin (Munich)       Date:  2006-10-15

2.  [Causal illness attributions and healthcare utilization in fibromyalgia syndrome].

Authors:  W Häuser; R Wilhelm; W Klein; C Zimmer
Journal:  Schmerz       Date:  2006-04       Impact factor: 1.107

3.  [Fibromyalgia in the legal procedures of the german sozialgericht -- psychosocial risk factors and predictors of health care utilization].

Authors:  Winfried Häuser
Journal:  Psychother Psychosom Med Psychol       Date:  2005-02

4.  Economic cost and epidemiological characteristics of patients with fibromyalgia claims.

Authors:  Rebecca L Robinson; Howard G Birnbaum; Melissa A Morley; Tamar Sisitsky; Paul E Greenberg; Ami J Claxton
Journal:  J Rheumatol       Date:  2003-06       Impact factor: 4.666

5.  Health services costs and their determinants in women with fibromyalgia.

Authors:  John R Penrod; Sasha Bernatsky; Viviane Adam; Murray Baron; Natalie Dayan; Patricia L Dobkin
Journal:  J Rheumatol       Date:  2004-07       Impact factor: 4.666

6.  [Health care utilization in patients with Fibromyalgia Syndrome (FMS)].

Authors:  A Müller; M Hartmann; W Eich
Journal:  Schmerz       Date:  2000-04       Impact factor: 1.107

7.  Depression and fibromyalgia: treatment and cost when diagnosed separately or concurrently.

Authors:  Rebecca L Robinson; Howard G Birnbaum; Melissa A Morley; Tamar Sisitsky; Paul E Greenberg; Frederick Wolfe
Journal:  J Rheumatol       Date:  2004-08       Impact factor: 4.666

  7 in total
  8 in total

Review 1.  [Epidural spinal cord stimulation for therapy of chronic pain. Summary of the S3 guidelines].

Authors:  V Tronnier; R Baron; F Birklein; S Eckert; H Harke; D Horstkotte; P Hügler; M Hüppe; B Kniesel; C Maier; G Schütze; R Thoma; R D Treede; V Vadokas
Journal:  Schmerz       Date:  2011-09       Impact factor: 1.107

2.  [Fibromyalgia syndrome guideline: Interim assessment].

Authors:  M Settan; S Eis; W Häuser
Journal:  Schmerz       Date:  2012-06       Impact factor: 1.107

3.  [Visualization of a myth--the new S3 guidelines for fibromyalgia syndrome].

Authors:  B Widder
Journal:  Schmerz       Date:  2009-02       Impact factor: 1.107

4.  [Treatment and healthcare costs of fibromyalgia syndrome in Germany: analysis of the data of the Barmer health insurance (BEK) from 2008-2009].

Authors:  U Marschall; B Arnold; W Häuser
Journal:  Schmerz       Date:  2011-08       Impact factor: 1.107

5.  [AWMF guidelines for fibromyalgia syndrome].

Authors:  W Hardinghaus
Journal:  Schmerz       Date:  2008-12       Impact factor: 1.107

6.  Patients' and professionals' views on managing fibromyalgia.

Authors:  Erica Briones-Vozmediano; Carmen Vives-Cases; Elena Ronda-Pérez; Diana Gil-González
Journal:  Pain Res Manag       Date:  2013 Jan-Feb       Impact factor: 3.037

7.  Fibromyalgia syndrome: classification, diagnosis, and treatment.

Authors:  Winfried Häuser; Wolfgang Eich; Markus Herrmann; Detlev O Nutzinger; Marcus Schiltenwolf; Peter Henningsen
Journal:  Dtsch Arztebl Int       Date:  2009-06-05       Impact factor: 5.594

Review 8.  [Fibromyalgia--the new guideline].

Authors:  W Brückle
Journal:  Z Rheumatol       Date:  2009-08       Impact factor: 1.372

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.